- €66.42bn
- €85.52bn
- €69.62bn
- 79
- 63
- 51
- 73
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 48,753 | 43,930 | 49,982 | 62,265 | 69,619 |
Cost of Revenue | |||||
Gross Profit | 38,371 | 34,249 | 39,310 | 47,371 | 53,829 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 43,089 | 41,471 | 45,544 | 55,776 | 61,548 |
Operating Profit | 5,664 | 2,459 | 4,438 | 6,489 | 8,071 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 5,042 | 1,823 | 3,820 | 6,154 | 7,020 |
Provision for Income Taxes | |||||
Net Income After Taxes | 3,408 | 1,016 | 2,195 | 4,417 | 5,103 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 3,260 | 1,242 | 2,597 | 4,260 | 4,703 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 3,260 | 1,242 | 2,597 | 4,259 | 4,702 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 5.81 | 2.34 | 4.61 | 7.44 | 8.3 |
Dividends per Share |